Dec 23, 2021· Comment from The Association for Accessible Medicines (AAM)· FDA-2020-N-1245-0007
Comments from the Association for Accessible Medicines (AAM) regarding FDA-2020-N-1245: Drug Products Approved in Abbreviated New Drug Applications Before the Enactment of the Hatch-Waxman Amendments; Establishment of a Public Docket.